INHIBITION OF RENAL RESERVE IN CHRONIC RENAL DISEASE |
|  | CG Musso, J Reynaldi, N Imperiali, L Algranati, DG Oreopoulos |
|
|
|
MITOCHONDRIAL GLUTATHIONE TRANSPORT IN DIABETIC NEPHROPATHY |
|  | Qing Zhong and Lawrence H. Lash |
|
|
|
WORLD KIDNEY DAY ACTIVITIES - A PILOT STUDY FOR THE PREVENTION OF KIDNEY DISEASES IN NIGERIA |
|  | H.A. Ugboma, F.U. Eke, I.C. Anochie |
|
|
|
SUMMARIES OF THE PRESENTATIONS OF THE CONFERENCE ON PREVENTION IN RENAL DISEASE 2007 |
|
|
|
Understanding the complexity of care for a patient with a vascular access |
|  | Charmaine Lok & Sandra Donnelly |
|
|
|
Chronic Kidney Disease: A public health problem that needs a public health action plan. |
|  | Thomas Hostetter |
|
|
|
Are “mega doses” of ACEs and ARBs worth their cost and risks? |
|  | Tomas Berl |
|
|
|
Primary prevention in diabetic renal disease: the story unfolds in Type I diabetes. |
|  | Sandra Donnelly |
|
|
|
Protein Kinase C (PKC) and progression of diabetic nephropathy |
|  | Catharine Whiteside |
|
|
|
Reactive oxygen species and progression of renal disease |
|  | Dimitrios Galaris |
|
|
|
Prevention of kidney stones |
|  | David Bushinsky |
|
|
|
Prevention of obstructive uropathy |
|  | Kenneth Pace |
|
|
|
Prevention of urinary tract infection: When should antimicrobials be used? |
|  | Lindsay Nicolle |
|
|
|
Advances in the treatment and management of severe hypertension and Type 2 diabetes |
|  | Robert Ting |
|
|
|
High normal blood pressure (BP) |
|  | Phil McFarlane |
|
|
|
Monoclonal antibodies |
|  | David Jayne |
|
|
|
Monoclonal antibodies in the treatment of membranous nephropathy – a novel approach |
|  | Paolo Cravedi |
|
|
|
IV immunoglobulins in glomerular diseases |
|  | Carl Cardella |
|
|
|
Genetics of renal diseases: Overview |
|  | Alain Bonnardeaux |
|
|
|
Novel treatment for autosomal dominant polycystic kidney disease (APKD): From bench to bedside |
|  | York Pei |
|
|
|
Fabry’s Disease: Is treatment effective? |
|  | Michael West |
|
|
|
Should nephroprevention start in utero? |
|  | Guido Filler |
|
|
|
Childhood hypertension: Role of obesity and uric acid and opportunities for prevention |
|  | Daniel Feig |
|
|
|
The Barker hypothesis - Fetal programming and increased cardiovascular and renal risk in adult life: Evidence and interventions |
|  | Eberhard Ritz |
|
|
|
Non-adherence in patients with diabetes and renal disease and thoughts on its improvement |
|  | Eli Friedman |
|
|
|
Improving non-adherence in renal transplant recipients by Internet usage |
|  | Amy Friedman |
|
|
|
Managing the CVD/CKD/ESRD Continuum- Primary prevention and lifestyle changes: principles of success |
|  | Adeera Levin |
|
|
|
Prevention of renal disease in Native Americans |
|  | Andrew Narva |
|
|
|
Chronic Disease Outreach Programs, Indigenous Australian and Soweto South Africa Experiences |
|  | Ivor Katz |
|
|
|
Prevention of renal disease in Mexico and South America |
|  | Bernardo Rodríguez-Iturbe |
|
|
|
|